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To the Editor:
The recent article by Snowden et al (1) is illuminat-
ing but does not mention the close relationship between 
late-life  depression  and  Alzheimer’s  disease.  Late-life 
depression  may  actually  be  an  early  manifestation  of 
Alzheimer’s  disease  itself.  Failure  to  recognize  subtle 
signs and symptoms can delay appropriate treatment, 
which is a major challenge in effectively treating depres-
sion in the elderly.
Rates of depression as high as 51% have been reported 
in patients with Alzheimer’s disease (2). In fact, recent 
studies indicate that late-life depression may be a sub-
stantial risk factor for Alzheimer’s disease (3). Wetherell 
et al have reported that elderly patients with depres-
sion are almost 4 times more likely than those without 
depression to develop Alzheimer’s disease, and this risk 
is even greater in those patients who report symptoms 
such  as  decreased  energy  levels  or  a  decline  in  inter-
est (4). Patients with Alzheimer’s disease who develop 
depression show decreased frontal lobe activity and glu-
cose hypometabolism, especially in the bilateral superior 
gyri and the left anterior cingulated gyri (5).
Physicians  should  be  aware  of  the  close  relationship 
between Alzheimer’s disease and depression. Recognizing 
Alzheimer’s disease and appropriately managing it can go 
a long way toward effectively treating late-life depression.
Shailendra Kapoor, MD
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